FDA NDC Directory · JSON-LD · Markdown

Ranolazine

NDC 72578-065 · HUMAN PRESCRIPTION DRUG · TABLET, EXTENDED RELEASE

Labeler / ManufacturerViona Pharmaceuticals Inc
Marketing categoryAbbreviated NDA (generic) · App ANDA210188
Dosage form / routeTABLET, EXTENDED RELEASE · ORAL
Active ingredientsRANOLAZINE (1000 mg/1)
Marketing started20190910
Package count4

External sources

Source: openFDA. Public-domain (CC0).